Pfizer’s Covid vaccine for young children may not be renewed by the US Food and Drug Administration (FDA) this fall, prompting Moderna to fill possible gaps in supply, according to an email obtained by the Guardian.
The move would pull the only remaining Covid vaccine for all children under five from the market.